Clinical

Dataset Information

0

A multicenter, single-arm phase II trial of bevacizumab beyond initial progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in Advanced Colorectal Cancer


ABSTRACT: Interventions: bevacizumab plus mFOLFOX6 therapy (first-line treatment) bevacizumab plus FOLFIRI therapy (second-line treatment) Primary outcome(s): 2nd progression free survival (2nd PFS) Study Design: Single arm Non-randomized

DISEASE(S): Untreated And Unresectable Metastatic Colorectal Cancer

PROVIDER: 2622240 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2024-08-26 | GSE275628 | GEO
| 2614860 | ecrin-mdr-crc
| 2289692 | ecrin-mdr-crc
2016-07-06 | GSE84010 | GEO
2009-11-16 | E-GEOD-18195 | biostudies-arrayexpress
2016-07-06 | E-GEOD-84010 | biostudies-arrayexpress
2023-04-19 | GSE208103 | GEO
| S-EPMC3493761 | biostudies-literature
| 2203761 | ecrin-mdr-crc
2013-01-03 | E-GEOD-19862 | biostudies-arrayexpress